Topic Highlight
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2012; 18(29): 3806-3813
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3806
Figure 1
Figure 1 Indication for early immunosuppressive therapy. Thiopurines and/or anti-tumor necrosis factor therapy, according to presentation of Crohn’s disease at diagnosis, 1European Crohn's and Colitis Organisation guidelines and 2Saint-Antoine predictors (2 or 3 of the following items at diagnosis are predictive for subsequent 5-year unfavourable course: Age < 40 years, need for systemic steroids and presence of perianal lesions). IT: Immunosuppressive therapy.